Jeff E. Knight
Chief Dev & Operating Officer; Chief Dev. & Operating Officer; Chief Operating Officer · 4 filings · Latest: Apr 16, 2026
ALX ONCOLOGY HOLDINGS INC
Crinetics Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRNX | JEFF KNIGHT | — | May 4, 2026 | Proposed Sale | $39.02 | 9,485 | $370.1K | — | |
CRNX | JEFF KNIGHT | — | Apr 14, 2026 | Proposed Sale | $38.66 | 20,900 | $808.0K | — | |
CRNX | JEFF KNIGHT | — | Apr 13, 2026 | Proposed Sale | $39.44 | 4,434 | $174.9K | — | |
CRNX | Jeff E. Knight | Chief Dev. & Operating Officer | Apr 8, 2026 | Sale | $40.10 | 85,163 | $3.4M | 105,289 | |
CRNX | Jeff E. Knight | Chief Dev. & Operating Officer | Apr 8, 2026 | Option Exercise | $22.42 | 78,434 | $1.8M | 190,452 | |
CRNX | JEFF KNIGHT | — | Apr 8, 2026 | Proposed Sale | $38.41 | 85,163 | $3.3M | — | |
CRNX | Jeff E. Knight | Chief Operating Officer | Mar 16, 2026 | Sale | $37.37 | 9,911 | $370.4K | 112,018 | |
CRNX | Jeff Knight | — | Mar 16, 2026 | Proposed Sale | $37.49 | 25,113 | $941.5K | — |